Beta blockers and fracture risk in osteoporosis

This study wants to see if it is safe for postmenopausal women with osteoporosis to stop taking Alendronate after a long period of treatment without any new fractures. If you have been on Alendronate for a while and have stayed fracture-free, you may be able to take a break from the medicine.

This study looks at whether starting a new blood pressure medicine might make you more likely to break a bone shortly after you start taking it. It is an observational study, meaning the researchers will just track people who are already starting these medicines to see if any fractures happen.

This trial studies whether doing a structured bone-focused exercise program, taking alendronate (a medication that slows bone loss), and making a calorie-reducing diet can improve bone strength in people with low bone density. It also compares different combinations to see what helps most and is safest for you.

This trial tests whether the drug alendronate can help prevent stress fractures (small breaks) in the pelvic bones of women with cervical cancer who are getting chemotherapy and radiation. It aims to reduce bone pain and improve bone health during treatment.

This study looks at how the natural aging of the body might affect how well bone-strengthening medications work for osteoporosis. If you are about to start one of these medications, the study will track your bone density over time to see how your response may differ based on your 'biological age.'

This trial tests if beta-blocker medication improves blood flow and reduces resistance in the tiny blood vessels of the heart in people who have chest pain but no major blockages in their arteries.